Insider Transactions in Q2 2022 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
72,223
+1.72%
|
$8,811,206
$122.83 P/Share
|
|
Jun 29
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
47,777
+0.6%
|
$5,876,571
$123.67 P/Share
|
|
Jun 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$550,000
$110.9 P/Share
|
|
Jun 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
May 31
2022
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
106,485
+50.0%
|
-
|
|
May 31
2022
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
106,485
-100.0%
|
-
|
|
May 27
2022
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
106,485
+50.0%
|
-
|
|
May 27
2022
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
106,485
-100.0%
|
-
|
|
May 27
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$110,000
$110.0 P/Share
|
|
May 27
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
May 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$520,000
$104.1 P/Share
|
|
May 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$45,000
$9.2 P/Share
|
|
Apr 21
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40
-0.16%
|
$5,360
$134.46 P/Share
|
|
Apr 21
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40
+0.16%
|
$360
$9.2 P/Share
|
|
Apr 20
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
704
-2.74%
|
$93,632
$133.2 P/Share
|
|
Apr 20
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
704
+2.67%
|
$6,336
$9.2 P/Share
|
|
Apr 19
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,500
-12.29%
|
$455,000
$130.81 P/Share
|
|
Apr 19
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+10.95%
|
$31,500
$9.2 P/Share
|
|
Apr 01
2022
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
47
+6.44%
|
$6,063
$129.38 P/Share
|
|
Apr 01
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-34.0%
|
$989,184
$128.45 P/Share
|
|
Apr 01
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+19.83%
|
$61,368
$6.36 P/Share
|